October 10, 2007 (Seattle) — A report from a military emergency unit in Iraq may indicate that a change in the timing of administration of recombinant factor VIIa (rFVIIa) could significantly improve ...

NEW ORLEANS — A new trial of recombinant factor VIIa in patients with intracerebral hemorrhage (ICH) showed neutral overall results but raised the possibility that the therapy could help stop bleeding ...

NovoSeven RT is a prescription drug used to treat certain blood clotting disorders, including hemophilia. The drug is given as an intravenous (IV) infusion, which is an injection into a vein over a ...

Hemophilia A and B coagulation defects, which are caused by deficiencies of Factor VIII and Factor IX, respectively, can be bypassed by administration of recombinant Factor VIIa. However, the short ...

(RTTNews) - The board of Sino Biopharmaceutical (SBMFF) announced that the Group's self-developed Recombinant Human Coagulation Factor VIIa N01 for Injection, with brand name: Anqixin - has been ...

Baby girl BC was born by cesarean section at 33 weeks of a monoamniotic-monochorionic-twin gestation complicated by growth discordance. At birth, her twin sister weighed 2.34 kg and had a hematocrit ...

Credit: Shutterstock. The FDA has approved Sevenfact (coagulation factor VIIa [recombinant]-jncw; LFB Biotechnologies) for the treatment and control of bleeding episodes occurring in patients aged ≥12 ...

Hematology researchers have further refined how a treatment currently used on an urgent basis to control bleeding in hemophilia patients holds promise as a preventive treatment as well. A study in ...

Recombinant Coagulation Factor VIIa (rFVIIa) Room Temperature Stable 1mg, 2mg, 5mg, 8mg; per vial; lyophilized pwd for IV inj after reconstitution; preservative-free. Novoseven RT is recombinant ...

Hematology researchers have further refined how a treatment currently used on an urgent basis to control bleeding in hemophilia patients holds promise as a preventive treatment as well. A study in ...